Claudia Pauligk - Institut für Klinische Forschung und Klinik für Onkologie und Hämatologie, am Krankenhaus Nordwest

Thorsten Goetze, Pompiliu Piso,Ulli Simone Bankstahl,Claudia Pauligk, Claudia Volk, Fabienne Knapp,Disorn Sookthai,Sylvie Lorenzen,Michael Schenk, Armin Wiegering, Peter Jo,Jens Werner, Jens Peter Hoelzen, Daniel E. Stange,Alexander Stein, Harald Schmalenberg, Metin Senkal, Salah-Eddin Al-Batran

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 359-359

Cited0Views0Bibtex

1472Tip Organ Preservation with Durvalumab-Based Immunotherapy in Combination with Chemoradiation As Definitive Therapy for Early Stage, Ct1 and Ct2n0, Esophageal Adenocarcinoma: A Prospective, Multicenter Study of the FLOT-AIO Gastric Cancer Group – the IKF-057/ PRESTO Trial

N. Homann,T.O. Goetze, D. Janke, S. Kubicka, C. Müller, D. Pink, C. Dietrich,S. Ertl, S. Glag,T. Habibzada, S. Neumann, A. West, U. Tenekeci, C. Kopp,C. Pauligk,S-E. Al-Batran

Annals of Oncology (2024)

Cited0Views0Bibtex

Treatment Landscape, Outcome and Quality of Life in Patients with Pancreatic Cancer: IKF642/PARAGON Study

Thorsten Goetze, Ruediger Liersch, Lars Scheuer, Thomas Gohler,Ulrich Kaiser, Claudio Denzlinger,Daniel Pink, Jan Wierecky, Jorge Klagges,Claudia Pauligk, Bianca Zapf, Ralf-Dieter Hofheinz, Salah-Eddin Al-Batran, Krankenhaus Nordwest

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

LBA25 Randomized Phase III Trial of Ramucirumab in Combination with TAS102 (trifluridin/tipiracil) Vs. TAS102 Monotherapy in Heavily Pretreated Metastatic Colorectal Cancer: the RAMTAS/IKF643 Trial of the German AIO (AIO-KRK-0316)

S. Kasper-Virchow, R.D. Hofheinz, S. Stintzing, T.N. Dechow,T.J. Ettrich, M. Sinn,C. Roderburg,L. Fischer von Weikersthal, U. Graeven, C. Mueller, J. Meiler, A. Stein,D.P. Modest,C. Pauligk,I. Virchow,J.T. Siveke,S-E. Al-Batran,M.H.H. Schuler,T.O. Goetze

Annals of Oncology (2024)

Cited0Views0Bibtex

Organ Preservation with Durvalumab-Based Immunotherapy in Combination with Chemoradiation As Definitive Therapy for Early Stage, Ct1, and Ct2n0 Esophageal Adenocarcinoma with Indication for Radical Surgery: A Prospective, Multicenter Study of the FLOT-AIO Gastric Cancer Group (Ikf-T057/presto Trial)

Thorsten Goetze,Stefan Angermeier, Juergen Debus,Vera Heuer,Nils Homann, Stephan Kanzler, Stefan Kubicka, Ruediger Liersch,Sylvie Lorenzen,Rolf Mahlberg, Christian Mueller, Lothar Mueller,Daniel Pink, Mark Reinwald, Ulrich Ronellenfitsch, Ludwig Fischer von Weikersthal, Ulas Tenekeci,Claudia Pauligk, Salah-Eddin Al-Batran

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): TPS431-TPS431

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn